In mammals, TTP is critical for the downregulation of HXKII expression in cancer cells as it enhances the degradation of the HXKII transcript, thus, suppressing the glycolytic capacity of cancer cells and reducing both the extracellular acidification rate and the oxygen consumption rate of cancer cells (Kim et al., 2019). This evidence concerns the gene ZFP36 and cancer.